Iris BioTechnologies, Inc., a life science company, develops solutions for the detection and monitoring of monogenic and complex genomic diseases. It is developing nano-biochip technology platform used for the diagnosis and treatment of patients with breast cancer, neurological disorders, heart diseases, diabetes, and other gene-related metabolic problems. The company also develops BioWindows, an artificial intelligence system, which provides data and analysis for clinical applications, drug development, and stem cell research. Iris BioTechnologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.
Industry, Sector and Symbol
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Phone+1-408-8672885
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees7
Next Earnings DateN/A
OptionableNot Optionable
Iris BioTechnologies (OTCMKTS:IRSB) Frequently Asked Questions
What is Iris BioTechnologies' stock symbol?
Iris BioTechnologies trades on the OTCMKTS under the ticker symbol "IRSB."
How were Iris BioTechnologies' earnings last quarter?
Has Iris BioTechnologies been receiving favorable news coverage?
News articles about IRSB stock have been trending extremely negative on Tuesday, InfoTrie reports. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Iris BioTechnologies earned a news impact score of -5.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Iris BioTechnologies.
Who are some of Iris BioTechnologies' key competitors?
Some companies that are related to Iris BioTechnologies include Ambu A/S (AMBBY), ANSELL LTD/S (ANSLY), CONVATEC GRP PL/ADR (CNVVY), Demant A/S (WILLF), Essilor International Cmgn Gnl D Optq (EI), Fisher & Paykel Healthcare (FSPKF), IsoRay (ISR), Lifestyle Delivery Systems (LDS), Lifestyle Delivery Systems (LDSYF), Medigard (MGZ), SECTOR 10 (SECI), STRAUMANN HLDG/ADR (SAUHY) and Straumann (SDMHF).
Who are Iris BioTechnologies' key executives?
Iris BioTechnologies' management team includes the folowing people:
- Mr. Simon S. M. Chin MBA, Founder, Chairman, Chief Exec. Officer, Pres, Chief Financial Officer and Sec. (Age 60)
- Mr. James LeBlanc MBA, VP of Operations (Age 72)
- Dr. Paul Yaswen Ph.D., Chief Scientific Officer (Age 61)
- Ms. Grace Osborne MBA, VP of Bus. Devel. & HR and Director (Age 52)
- Dr. Ronald Mark Gemberling M.D., Chief Medical Officer (Age 72)
How do I buy shares of Iris BioTechnologies?
Shares of IRSB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Iris BioTechnologies' stock price today?
One share of IRSB stock can currently be purchased for approximately $0.04.
What is Iris BioTechnologies' official website?
How can I contact Iris BioTechnologies?
Iris BioTechnologies' mailing address is 5201 Great America Pkwy Ste 320, SANTA CLARA, CA 95054-1140, United States. The company can be reached via phone at +1-408-8672885.
MarketBeat Community Rating for Iris BioTechnologies (OTCMKTS IRSB)
MarketBeat's community ratings are surveys of what our community members think about Iris BioTechnologies and other stocks. Vote "Outperform" if you believe IRSB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IRSB will underperform the S&P 500 over the long term. You may vote once every thirty days.
